{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T19:28:19Z","timestamp":1773948499237,"version":"3.50.1"},"reference-count":35,"publisher":"Stanford University Press","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"vor","delay-in-days":16,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Mass Spectrometry and Advances in the Clinical Lab"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.jmsacl.2025.04.006","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T13:12:57Z","timestamp":1744895577000},"page":"46-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Quantification of total sBCMA in human plasma by peptide-level immunocapture LC-MS\/MS"],"prefix":"10.21627","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3184-9440","authenticated-orcid":false,"given":"Johanna","family":"Paris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Tavernier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvie","family":"Bethegnies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandrine","family":"Descloux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Fedeli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4811","reference":[{"key":"10.1016\/j.jmsacl.2025.04.006_b0005","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1084\/jem.20031330","article-title":"BCMA is essential for the survival of long-lived bone marrow plasma cells","volume":"199","author":"O\u2019Connor","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jmsacl.2025.04.006_b0010","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/bjh.14145","article-title":"Evaluation of B cell maturation antigen as a target for antibody drug conjugate mediated cytotoxicity in multiple myeloma","volume":"174","author":"Lee","year":"2016","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.jmsacl.2025.04.006_b0015","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1158\/1535-7163.MCT-20-0287","article-title":"HDP-101, an anti-BCMA antibody\u2013drug conjugate, safely delivers amanitin to induce cell death in proliferating and resting multiple myeloma cells","volume":"20","author":"Figueroa-Vazquez","year":"2021","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jmsacl.2025.04.006_b0020","doi-asserted-by":"crossref","first-page":"5288","DOI":"10.1021\/jacs.5b01876","article-title":"An anti\u2013B cell maturation antigen bispecific antibody for multiple myeloma","volume":"137","author":"Ramadoss","year":"2015","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jmsacl.2025.04.006_b0025","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1158\/1078-0432.CCR-12-2422","article-title":"B-cell maturation antigen is a promising target for adoptive T-cell therapy of multiple myeloma","volume":"19","author":"Carpenter","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jmsacl.2025.04.006_b0030","first-page":"1","article-title":"Phase I study of safety and pharmacokinetics of RO7297089, an anti-BCMA\/CD16a bispecific antibody, in patients with relapsed, refractory multiple myeloma","author":"Plesner","year":"2023","journal-title":"Clin Hematology Int"},{"key":"10.1016\/j.jmsacl.2025.04.006_b0035","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3390\/immuno3020016","article-title":"Immunotherapeutic development of a tri-specific NK cell engager recognizing BCMA","volume":"3","author":"Oh","year":"2023","journal-title":"Immuno"},{"key":"10.1016\/j.jmsacl.2025.04.006_b0040","doi-asserted-by":"crossref","first-page":"7333","DOI":"10.1038\/ncomms8333","article-title":"\u03b3-secretase directly sheds the survival receptor BCMA from plasma cells","volume":"6","author":"Laurent","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jmsacl.2025.04.006_b0045","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/10428194.2022.2133540","article-title":"The role of soluble B cell maturation antigen as a biomarker in multiple myeloma","volume":"64","author":"Alomari","year":"2023","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.jmsacl.2025.04.006_b0050","doi-asserted-by":"crossref","DOI":"10.3389\/pore.2023.1611171","article-title":"Soluble B-cell maturation antigen as a monitoring marker for multiple myeloma","volume":"29","author":"Wiedemann","year":"2023","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.jmsacl.2025.04.006_b0055","doi-asserted-by":"crossref","first-page":"785","DOI":"10.3324\/haematol.2016.150896","article-title":"Serum B-cell maturation antigen: a novel biomarker to predict outcomes for multiple myeloma patients","volume":"102","author":"Ghermezi","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.jmsacl.2025.04.006_b0060","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/j.1365-2141.2012.09241.x","article-title":"Serum B\u2010cell maturation antigen is elevated in multiple myeloma and correlates with disease status and survival","volume":"158","author":"Sanchez","year":"2012","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.jmsacl.2025.04.006_b0065","doi-asserted-by":"crossref","first-page":"e174","DOI":"10.1016\/j.clml.2019.09.291","article-title":"Normalization of serum B-cell maturation antigen levels predicts progression free and overall survival in multiple myeloma patients starting treatment","volume":"19","author":"Jew","year":"2019","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"10.1016\/j.jmsacl.2025.04.006_b0070","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/hon.2961","article-title":"Use of serum B\u2010cell maturation antigen levels to predict outcomes for myeloma patients treated with ruxolitinib, lenalidomide and methylprednisolone","volume":"40","author":"Bujarski","year":"2022","journal-title":"Hematol. Oncol."},{"key":"10.1016\/j.jmsacl.2025.04.006_b0075","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1021\/ac7021234","article-title":"Immunopurification and mass spectrometric quantification of the active form of a chimeric therapeutic antibody in human serum","volume":"80","author":"Dubois","year":"2008","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jmsacl.2025.04.006_b0080","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ab.2006.12.023","article-title":"Antibody-based enrichment of peptides on magnetic beads for mass-spectrometry-based quantification of serum biomarkers","volume":"362","author":"Whiteaker","year":"2007","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jmsacl.2025.04.006_b0085","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.1021\/ac070051f","article-title":"Strategic use of immunoprecipitation and LC\/MS\/MS for trace-level protein quantification: myosin light chain 1, a biomarker of cardiac necrosis","volume":"79","author":"Berna","year":"2007","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jmsacl.2025.04.006_b0090","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1021\/ac50048a002","article-title":"Triple quadrupole mass spectrometry for direct mixture analysis and structure elucidation","volume":"51","author":"Yost","year":"1979","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jmsacl.2025.04.006_b0095","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jim.2009.06.003","article-title":"The fundamental flaws of immunoassays and potential solutions using tandem mass spectrometry","volume":"347","author":"Hoofnagle","year":"2009","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.jmsacl.2025.04.006_b0100","doi-asserted-by":"crossref","first-page":"985","DOI":"10.4155\/bio-2022-0058","article-title":"Method development workflow for quantifying protein biomarkers by hybrid LC\u2013MS\/MS","volume":"14","author":"Agrawal","year":"2022","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jmsacl.2025.04.006_b0105","doi-asserted-by":"crossref","DOI":"10.4155\/fsoa-2017-0148","article-title":"Opportunities and challenges for hybrid immunoaffinity LCMS approach for quantitative analysis of protein biomarkers","volume":"4","author":"Zhao","year":"2018","journal-title":"Futur. Sci. OA"},{"key":"10.1016\/j.jmsacl.2025.04.006_b0110","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.4155\/bio-2018-0205","article-title":"Perspectives on potentiating immunocapture-LCMS for the bioanalysis of biotherapeutics and biomarkers","volume":"10","author":"Sugimoto","year":"2018","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jmsacl.2025.04.006_b0115","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.aca.2019.03.033","article-title":"A multiplex liquid chromatography tandem mass spectrometry method for the quantification of seven therapeutic monoclonal antibodies: Application for adalimumab therapeutic drug monitoring in patients with Crohn\u2019s disease","volume":"1067","author":"Willeman","year":"2019","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jmsacl.2025.04.006_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2020.122047","article-title":"Development and validation of a method for quantification of human insulin and its synthetic analogues in plasma and post-mortem sera by LC-MS\/HRMS","volume":"225","author":"Bottinelli","year":"2021","journal-title":"Talanta"},{"key":"10.1016\/j.jmsacl.2025.04.006_b0125","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1089\/adt.2020.1024","article-title":"A flexible multiplatform bioanalytical strategy for measurement of total circulating shed target receptors: application to soluble B cell maturation antigen levels in the presence of a bispecific antibody drug","volume":"19","author":"Stauffer","year":"2021","journal-title":"Assay Drug Dev Techn"},{"key":"10.1016\/j.jmsacl.2025.04.006_b0130","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/clinchem\/hvad145","article-title":"Deciphering the exact sequence of endogenous soluble B cell maturation antigen and unbiased quantitation in multiple myeloma patient samples by LC-MS","volume":"70","author":"Shen","year":"2024","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jmsacl.2025.04.006_b0135","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1373\/clinchem.2009.123935","article-title":"Developing multiplexed assays for troponin i and interleukin-33 in plasma by peptide immunoaffinity enrichment and targeted mass spectrometry","volume":"55","author":"Kuhn","year":"2009","journal-title":"Clin Chem"},{"key":"10.1016\/j.jmsacl.2025.04.006_b0140","doi-asserted-by":"crossref","first-page":"5522","DOI":"10.1021\/ac4006765","article-title":"Highly specific and sensitive measurements of human and monkey interleukin 21 using sequential protein and tryptic peptide immunoaffinity LC-MS\/MS","volume":"85","author":"Palandra","year":"2013","journal-title":"Anal Chem"},{"key":"10.1016\/j.jmsacl.2025.04.006_b0145","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1373\/clinchem.2008.109652","article-title":"Quantification of Thyroglobulin, a Low-Abundance Serum Protein, by Immunoaffinity Peptide Enrichment and Tandem Mass Spectrometry","volume":"54","author":"Hoofnagle","year":"2008","journal-title":"Clin Chem"},{"key":"10.1016\/j.jmsacl.2025.04.006_b0150","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.nbt.2015.12.008","article-title":"High precision quantification of human plasma proteins using the automated SISCAPA Immuno-MS workflow","volume":"33","author":"Razavi","year":"2016","journal-title":"New Biotechnol"},{"key":"10.1016\/j.jmsacl.2025.04.006_b0155","doi-asserted-by":"crossref","first-page":"5642","DOI":"10.1021\/pr300652v","article-title":"High-throughput SISCAPA quantitation of peptides from human plasma digests by ultrafast, liquid chromatography-free mass spectrometry","volume":"11","author":"Razavi","year":"2012","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jmsacl.2025.04.006_b0160","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1021\/pr034086h","article-title":"Mass spectrometric quantitation of peptides and proteins using stable isotope standards and capture by anti-peptide antibodies (SISCAPA)","volume":"3","author":"Anderson","year":"2004","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jmsacl.2025.04.006_b0165","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.smim.2006.04.006","article-title":"BAFF, APRIL and their receptors: structure, function and signaling","volume":"18","author":"Bossen","year":"2006","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.jmsacl.2025.04.006_b0170","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1002\/pmic.201500540","article-title":"Commercially available antibodies can be applied in quantitative multiplexed peptide immunoaffinity enrichment targeted mass spectrometry assays","volume":"16","author":"Schoenherr","year":"2016","journal-title":"Proteomics"},{"key":"10.1016\/j.jmsacl.2025.04.006_b0175","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jmsacl.2022.09.005","article-title":"A distributable LC-MS\/MS method for the measurement of serum thyroglobulin","volume":"26","author":"Shi","year":"2022","journal-title":"J. Mass Spectrom. Adv. Clin. Lab"}],"container-title":["Journal of Mass Spectrometry and Advances in the Clinical Lab"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667145X25000136?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667145X25000136?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T07:22:50Z","timestamp":1767770570000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667145X25000136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":35,"alternative-id":["S2667145X25000136"],"URL":"https:\/\/doi.org\/10.1016\/j.jmsacl.2025.04.006","relation":{},"ISSN":["2667-145X"],"issn-type":[{"value":"2667-145X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantification of total sBCMA in human plasma by peptide-level immunocapture LC-MS\/MS","name":"articletitle","label":"Article Title"},{"value":"Journal of Mass Spectrometry and Advances in the Clinical Lab","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmsacl.2025.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 THE AUTHORS. Publishing services by ELSEVIER B.V. on behalf of MSACL.","name":"copyright","label":"Copyright"}]}}